Search

Author/Creator Jukema, Johan Wouter

1. Alirocumab after acute coronary syndrome in patients with a history of heart failure. (18th December 2021)

Authors:
White, Harvey D; Schwartz, Gregory G; Szarek, Michael; Bhatt, Deepak L; Bittner, Vera A; Chiang, Chern-En; Diaz, Rafael; Goodman, Shaun G; Jukema, Johan Wouter; Loy, Megan; Pagidipati, Neha; Pordy, Robert; Ristić, Arsen D; Zeiher, Andreas M; Wojdyla, Daniel M; Steg, Philippe Gabriel
Journal:
European heart journal
Issue:
Volume 43:Number 16(2022)
Page Start:
1554
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Comparison of P2Y12 receptor inhibitors in patients with ST-elevation myocardial infarction in clinical practice: a propensity score analysis of five contemporary European registries. Issue 2 (22nd January 2020)

Authors:
De Luca, Leonardo; Zeymer, Uwe; Claeys, Marc J; Dörler, Jakob; Erne, Paul; Matter, Christian M; Radovanovic, Dragana; Weidinger, Franz; Lüscher, Thomas F; Jukema, Johan Wouter
Journal:
European heart journal
Issue:
Volume 7:Issue 2(2021)
Page Start:
94
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Metabolic risk factors and effect of alirocumab on cardiovascular events after acute coronary syndrome: a post-hoc analysis of the ODYSSEY OUTCOMES randomised controlled trial. Issue 5 (May 2022)

Authors:
Ostadal, Petr; Steg, Philippe Gabriel; Poulouin, Yann; Bhatt, Deepak L; Bittner, Vera A; Chua, Terrence; Diaz, Rafael; Goodman, Shaun G; Huo, Yong; Jukema, Johan Wouter; Karpov, Yuri; Pordy, Robert; Scemama, Michel; Szarek, Michael; White, Harvey D; Schwartz, Gregory G
Journal:
Lancet
Issue:
Volume 10:Issue 5(2022)
Page Start:
330
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search